Search by Drug Name or NDC
NDC 00069-1975-40 Vyndaqel 20 mg/1 Details
Vyndaqel 20 mg/1
Vyndaqel is a ORAL CAPSULE, LIQUID FILLED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is TAFAMIDIS MEGLUMINE.
MedlinePlus Drug Summary
Tafamidis is used to treat transthyretin amyloid cardiomyopathy (ATTR-CM; a condition in which a protein (transthyretin) builds up in the wall of the heart making it thicker which makes it difficult for the heart to pump blood adequately). Tafamidis is in a class of medications called transthyretin stabilizers. It works by preventing the formation of transthyretin protein deposits in the heart.
Related Packages: 00069-1975-40Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tafamidis
Product Information
| NDC | 00069-1975 |
|---|---|
| Product ID | 0069-1975_847e5e9a-9978-4804-b542-320eba1fb9ad |
| Associated GPIs | 40550080200120 |
| GCN Sequence Number | 073210 |
| GCN Sequence Number Description | tafamidis meglumine CAPSULE 20 MG ORAL |
| HIC3 | P9A |
| HIC3 Description | PROTEIN STABILIZERS |
| GCN | 37584 |
| HICL Sequence Number | 041631 |
| HICL Sequence Number Description | TAFAMIDIS MEGLUMINE |
| Brand/Generic | Brand |
| Proprietary Name | Vyndaqel |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | tafamidis meglumine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | TAFAMIDIS MEGLUMINE |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA211996 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00069-1975-40 (00069197540)
| NDC Package Code | 0069-1975-40 |
|---|---|
| Billing NDC | 00069197540 |
| Package | 4 CARTON in 1 CARTON (0069-1975-40) / 30 BLISTER PACK in 1 CARTON / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0069-1975-12) |
| Marketing Start Date | 2019-05-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |